COVID-19

New Analysis Shows Reduction in Annual Patient Costs and Medical Claims with Medisafe

According to the analysis, MS and epilepsy patients experienced reduced annual healthcare costs of $6,280 and $4,600, respectively, on average…

1 year ago

Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs

Experienced Biopharma/Pharmaceutical Executive to Lead Implementation of cGMP-quality LineaDNA™ Capability for IVT mRNA ProductionPreviously Led Manufacturing Operations Scale-up for the…

1 year ago

Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion

TORONTO, ON / ACCESSWIRE / September 6, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today provided an…

1 year ago

Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86

CDC notes that the BA.2.86 (Pirola) variant may be more likely to break through existing immunity from previous vaccination or…

1 year ago

Palisade Bio Transforms GI-Focused Pipeline Through Exclusive Worldwide Licensing Agreement with Giiant Pharma, Inc. for Multiple Oral Drug Candidates Targeting Inflammatory Bowel Disease

– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of I ND-enabling studies with IND…

1 year ago

Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial of AWKN-P001

AWKN-P001 is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for the Treatment of Severe Alcohol Use DisorderToronto,…

1 year ago

Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio

ANN ARBOR, MI / ACCESSWIRE / September 5, 2023 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary…

1 year ago

NervGen Pharma to Present on Its Drug Candidate NVG-291 and Spinal Cord Injury at the H.C. Wainwright 25th Annual Global Investment Conference

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech…

1 year ago

Red Light Holland Submits Permit Application to the Township of Cavan-Monaghan for the Company’s 65,000 Square Foot Mushroom Farm

Red Light Holland's submission of the permit application to the township of Cavan-Monaghan (Peterborough, Ontario) on its 100 acres of…

1 year ago

Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan

First Batch of 300,000 Units to be Fully Delivered in OctoberAinos Has Expanded Distribution in Multiple Channels and Plans to…

1 year ago